Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine for Adductor Canal Block in TKA
NCT03182933Phase 4Terminated
- Sponsor
- University of Wisconsin–Madison
- Start
- May 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in postoperative pain, sponsored by University of Wisconsin–Madison. Started May 2017; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03182933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03182933.